Structural Formula (Zol10 0002 01)
Zoledronic Acid Injection, Solution
Product Images NDC 71288-806
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 71288-806). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Zol10 0002 02)
Vial Label (Zol10 0002 03)
This is a medication packaging label containing information such as the NDC number, dosage, administration instructions, and manufacturer details. No further information is available.*
Carton (Zol10 0002 04)
This text contains information about zoledronic acid injection for intravenous use. Each bottle contains 5,330 mg of zoledronic acid, equivalent to 5 mg on an anhydrous basis. The solution must not be mixed with calcium-containing solutions and should be administered as a single intravenous solution through a separate vented infusion line. The solution is stable for 24 hours after opening when refrigerated between 2 and 8°C. The container closure is not made with natural rubber latex. Dosage and administration instructions are available in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
